Yüklüyor......
Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
Triple-negative breast cancer (TNBC) remains the poorest-prognosis breast cancer (BC) subtype. Gene expression profiling has identified at least six different triple-negative subtypes with different biology and sensitivity to therapies. The heterogeneous nature of TN tumors may justify the difficult...
Kaydedildi:
| Yayımlandı: | Cancer Manag Res |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5772398/ https://ncbi.nlm.nih.gov/pubmed/29391830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S146658 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|